Search for: "Ely Lilly" Results 521 - 540 of 2,173
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Sep 2008, 4:36 am
The plaintiffs claim that the drug giant Eli Lilly committed fraud by pricing its anti-psychotic drug Zyprexa too high and overemphasizing Zyprexa's utility. [read post]
21 Oct 2008, 6:21 am
Here is a partial list: Prasugrel, a blood thinner from Eli Lilly and Daiichi Sankyo. [read post]
12 Apr 2014, 10:50 am
Some of the condition’s researchers have helped Eli Lilly investigate how its flagship A.D.H.D. drug might treat it. [read post]
18 Feb 2008, 10:06 am
New claims against Eli Lilly Co. over harmful side effects of the defective drug Zyprexa have now brought the total number of drug settlements to over 25,000. 900 new cases, including 5 that were set to go to trial in February, were settled recently, leaving the total number of unsettled cases at 1,100. [read post]
13 Nov 2003, 3:50 am
The Securities and Exchange Commission is asking Eli Lilly & Co. for documents in a review of possible violations involving their Polish drug [read post]
25 Aug 2009, 4:06 am
--> Byetta is a drug that's manufactured by Eli Lilly and Co., and it originally hit the market in the United States after obtaining approval from the FDA in 2005. [read post]
16 Aug 2021, 2:15 pm by Eileen McDermott
Court of Appeals for the Federal Circuit today issued two precedential decisions and one nonprecedential decision in cases involving Teva Pharmaceuticals and Eli Lilly, delivering wins and losses for each company. [read post]
18 Jun 2014, 9:30 am by Pete Strom
Blue Cross Files Actos Lawsuit On Behalf of Its Members Insurance company Blue Cross has filed an Actos lawsuit against Takeda Pharmaceuticals and their American distributor, Eli Lilly, alleging personal injury on behalf of their insureds who took Actos. [read post]
26 Aug 2014, 11:44 am by Pete Strom
28 Plaintiffs in Cymbalta MDL May Get Moved to California A multidistrict litigation (MDL) against Cymbalta, from pharmaceutical manufacturer Eli Lilly, claims that plaintiffs faced serious withdrawal symptoms when they stopped taking the antidepressant, including “brain zaps” and other debilitating health problems. [read post]
9 Nov 2011, 1:49 am by Marie Louise
  Highlights this week included: UK Supreme Court: Industrial application and biotech patents: Human Genome Sciences v Eli Lilly (EPLAW) (IPKat) (IPKat) (Patently-O) (Sufficient Description) (IAM)   Please join the discussion by adding your [...] [read post]
1 Aug 2014, 7:47 am by Pete Strom
Judge Will Not Overturn Actos Verdict, Takeda Still Owes $9 Billion Takeda Pharmaceuticals and Eli Lilly still owe plaintiffs in the first Actos verdict $9 billion in punitive damages, according to the judge. [read post]
26 Oct 2021, 4:15 am by Jack Lu
As an example, Eli Lilly stock price jumped 10.2% on June 7, or a hike of... [read post]
5 Feb 2009, 8:06 pm
Eli Lilly & Co., after agreeing to spend more than $2.6 billion to settle government and individual product liability claims over its antipsychotic drug Zyprexa, still faces product liability lawsuits over the drugs. [read post]
7 Jul 2015, 1:55 pm
Indianapolis, Indiana - In conjunction with non-Indiana co-counsel, an Indiana patent attorney for Eli Lilly and Company, Eli Lilly Export S.A. [read post]
9 Dec 2021, 11:02 am by Tom Lamb
As we wrote about in this recent article, "Eli Lilly Attempts to Distance Olumiant From the Ominous JAK Inhibitors Drug Class Safety Issues Flagged by FDA", the pharmaceutical companies AbbieVie and Eli Lilly have attempted to distinguish the safety profile of their respective JAK inhibitors drug product from the various adverse drug reactions that have been observed in the Xeljanz clinical trial that have driven the FDA regulatory actions driving these… [read post]
2 Feb 2015, 5:58 am
Indianapolis, Indiana - An Indiana patent attorney for Eli Lilly and Company ("Lilly") of Indianapolis, Indiana filed an intellectual property lawsuit in the Southern District of Indiana alleging that Fresenius Kabi USA, LLC ("Fresenius") of Lake Zurich, Illinois infringed the patented product ALIMTA®, Patent No. 7,772,209, which has been registered by the U.S. [read post]